News Updates

More Articles Back to Article

IVI, Nankai team up for vaccine research, development

International Vaccine Institute in Korea and Nankai University in China have signed a Memorandum of Understanding to establish the IVI Nankai Joint Vaccine Centre, aiming to promote cooperation in innovative vaccine research and development and contribute to global public health security. The partnership is expected to benefit China's vaccine industry, support economic development, address medical product shortages in developing countries and advance global public health. BioSpectrum Asia (5/23)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!